Overview

A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending dose of ASP0456 in non-elderly healthy subjects. Two dosing condition, pre-prandial and postprandial administrations, is compared.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Linaclotide